| Title | The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. | ||
| Author | Garg, Ravendra; Shrivastava, Pratima; van Drunen Littel-van den Hurk, Sylvia | ||
| Journal | Expert Rev Vaccines | Publication Year/Month | 2012-Dec |
| PMID | 23252388 | PMCID | -N/A- |
| Affiliation | 1.VIDO-Intervac, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada. | ||
Respiratory syncytial virus (RSV) is a common human pathogen that causes cold-like symptoms in most healthy adults and children. However, RSV often moves into the lower respiratory tract in infants and young children predisposed to respiratory illness, making it the most common cause of pediatric broncheolitis and pneumonia. The development of an appropriate balanced immune response is critical for recovery from RSV, while an unbalanced and/or excessively vigorous response may lead to immunopathogenesis. Different dendritic cell (DC) subsets influence the magnitude and quality of the host response to RSV infection, with myeloid DCs mediating and plasmacytoid DCs modulating immunopathology. Furthermore, stimulation of DCs through Toll-like receptors is essential for induction of protective immunity to RSV. These characteristics have implications for the rational design of a RSV vaccine.